120 related articles for article (PubMed ID: 28224656)
1. Diagnosis and management of lentigo maligna: an observational study comparing 2005 with 2014 data in one institution.
Hawkey S; Affleck A
Clin Exp Dermatol; 2017 Apr; 42(3):320-323. PubMed ID: 28224656
[TBL] [Abstract][Full Text] [Related]
2. Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.
Tio D; Prinsen CAC; Dréno B; Hoekzema R; Augustin M; van Montfrans C
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1476-1484. PubMed ID: 29419913
[TBL] [Abstract][Full Text] [Related]
3. Lentigo maligna: current concepts in diagnosis and management.
Walling HW
G Ital Dermatol Venereol; 2009 Apr; 144(2):149-55. PubMed ID: 19357622
[TBL] [Abstract][Full Text] [Related]
4. Lentigo maligna and lentigo maligna melanoma.
Cohen LM
J Am Acad Dermatol; 1995 Dec; 33(6):923-36; quiz 937-40. PubMed ID: 7490362
[TBL] [Abstract][Full Text] [Related]
5. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment.
McKenna JK; Florell SR; Goldman GD; Bowen GM
Dermatol Surg; 2006 Apr; 32(4):493-504. PubMed ID: 16681656
[TBL] [Abstract][Full Text] [Related]
6. Management of lentigo maligna.
Christenson LJ
Dermatol Nurs; 2004 Dec; 16(6):495-8, 505, 523. PubMed ID: 15690926
[TBL] [Abstract][Full Text] [Related]
7. Lentigo maligna melanoma--the review.
Situm M; Bolanca Z; Buljan M
Coll Antropol; 2010 Apr; 34 Suppl 2():299-301. PubMed ID: 21305747
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic techniques in lentigo maligna: an update.
Collgros H; Lamas-Doménech N
Actas Dermosifiliogr; 2015 Mar; 106(2):135-6. PubMed ID: 25439146
[No Abstract] [Full Text] [Related]
9. Lentigo maligna: a review.
Karponis D; Stratigos IA; Joshy J; Craig PJ; Mistry K; van Bodegraven B; Venables ZC; Levell NJ
Clin Exp Dermatol; 2024 Feb; 49(3):218-225. PubMed ID: 37966718
[TBL] [Abstract][Full Text] [Related]
10. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
Erickson C; Miller SJ
Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
[TBL] [Abstract][Full Text] [Related]
12. Lentigo maligna: diagnosis and treatment.
Bosbous MW; Dzwierzynski WW; Neuburg M
Clin Plast Surg; 2010 Jan; 37(1):35-46. PubMed ID: 19914456
[TBL] [Abstract][Full Text] [Related]
13. Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007.
Mirzoyev SA; Knudson RM; Reed KB; Hou JL; Lohse CM; Frohm ML; Brewer JD; Otley CC; Roenigk RK
J Am Acad Dermatol; 2014 Mar; 70(3):443-8. PubMed ID: 24373777
[TBL] [Abstract][Full Text] [Related]
14. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
15. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy.
Guitera P; Moloney FJ; Menzies SW; Stretch JR; Quinn MJ; Hong A; Fogarty G; Scolyer RA
JAMA Dermatol; 2013 Jun; 149(6):692-8. PubMed ID: 23553208
[TBL] [Abstract][Full Text] [Related]
16. Lentigo maligna.
Smalberger GJ; Siegel DM; Khachemoune A
Dermatol Ther; 2008; 21(6):439-46. PubMed ID: 19076621
[TBL] [Abstract][Full Text] [Related]
17. Reflectance confocal microscopy for recurrent lentigo maligna.
Erfan N; Kang HY; Cardot-Leccia N; Chignon-Sicard B; Passeron T; Ortonne JP; Lacour JP; Bahadoran P
Dermatol Surg; 2011 Oct; 37(10):1519-24. PubMed ID: 21790847
[No Abstract] [Full Text] [Related]
18. A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod.
de Vries K; Rellum R; Habets JM; Prens EP
Br J Dermatol; 2013 Jun; 168(6):1362-4. PubMed ID: 23252724
[No Abstract] [Full Text] [Related]
19. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
20. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
